FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.
OTC Showcase's picture

Email

Profile

User Points

  • General: 800
Total (all categories): 100

History

No activity yet.

See More

Markets Fall on Wednesday, Dow Jones Down Four out of Five Days
Posted by OTC Showcase on October 24th, 2012

Stocks traded in a narrow range Wednesday afternoon, as investors found little reason to place any big bets with earnings season in full-bloom. Earnings and outlooks are keeping investors on the sidelines as business overseas is hamstringing growth for major corporations. The Wall Street slide on Wednesday added to triple-digit losses on Tuesday and made it four out of five days with red closes that have yanked almost 500 points from the Dow Jones Industrial Average. Today’s close for the Dow was its lowest since September 3.

Read More
comment 0
Share
Tickers:
N/A
Tags:
General Market News, dow jones industrial average closing price, stock market commentary, blue chip stocks, Nasdaq news, S&P 500 news, end of day stock market, market reports

Excellagen Presentation on Cardium Therapeutics Website
Posted by OTC Showcase on October 24th, 2012

An updated presentation for Excellagen has been published on the Cardium Therapeutics (NYSE MKT: CXM) website.  The pdf file is available for viewing/dowloading at http://phx.corporate-ir.net/phoenix.zhtml?c=77949&p=irol-presentations.

Read More
comment 0
Share
Tickers:
CXM
Tags:
General Market News, Cardium Therapeutics, CXM, cardiovascular disease, gene therapy, Diabetic Foot Wounds, diabetic foot ulcers, dna therapy, regenerative medicine stocks, Excellagen, generx, wound care, surgical would care, Noble Financial, MedPodium, dna therapy, To Go Brands

ALR Technologies Adds Board Members, Readies for Commercialization
Posted by OTC Showcase on September 4th, 2012

Read More
comment 0
Share
Tickers:
N/A
Tags:
General Market News, ALR Technologies, ALRT, Diabetes management, remote diabetes care, internet based glucose monitoring, Diabetic Care, Health-e-Connect, healthcare companies

Greater Adherence to Diabetes Management Plans Could Save Billions
Posted by OTC Showcase on August 21st, 2012

Read More
comment 0
Share
Tickers:
N/A
Tags:
Economy, Diabetes management, savings, costs associated with diabetes, diabetes management systems, ALR Technologies, ALRT, ALRT stock quote, ALRT news, lower A1c, lower glycated hemoglobin

Cardium Therapeutics Releases New Excellagen Case Studies
Posted by OTC Showcase on August 14th, 2012

Cardium Therapeutics (NYSE MKT: CXM) has released new case study information on its Excellagen wound care management product.

Read More
comment 0
Share
Tickers:
CXM
Tags:
Penny Stock News, Cardium Therapeutics, CXM, cardiovascular disease, gene therapy, Diabetic Foot Wounds, diabetic foot ulcers, dna therapy, regenerative medicine stocks, Excellagen, generx

Cardium's Excellagen® Named As Top 10 Innovation In Podiatry
Posted by OTC Showcase on August 1st, 2012

Cardium Therapeutics (NYSE MKT: CXM) today announced that its professional-use Excellagen® (formulated collagen gel 2.6%) wound care product was selected as one of the top ten podiatry innovations in 2012 by the publication Podiatry Today. The Company also announced that it will be introducing Excellagen at the American Podiatric Medical Association (APMA) National Meeting (Booth 1910) being held August 16 – 19, 2012 in Washington, DC.

Read More
comment 0
Share
Tickers:
CXM
Tags:
Penny Stock News, Cardium Therapeutics, CXM, cardiovascular disease, gene therapy, Diabetic Foot Wounds, diabetic foot ulcers, dna therapy, regenerative medicine stocks, Excellagen, Regenx

Cardium CEO Discusses Generx, Excellagen and MedPodium with CEOCFOInterviews.com
Posted by OTC Showcase on July 16th, 2012

Read More
comment 0
Share
Tickers:
CXM
Tags:
Penny Stock News, cardiovascular disease, Cardium Therapeutics, Cell Therapy, chronic wound care, CXM, diabetic foot ulcers, diabetic ulcers, diabetic wounds, dna therapy, Excellagen, gene therapy, generx, regenerative medicine, stem cells, MedPodium, coronary artery disease

Pages